Circulating MicroRNAs as Potential Biomarkers for Parkinson Disease Diagnosis
In a meta-analysis, researchers evaluated the diagnostic accuracy of circulating miRNAs in the diagnosis of PD.
Parkinson Disease
Supernus One Step Closer to Decision on Apomorphine Infusion Device
SPN-830 provides a continuous subcutaneous infusion of apomorphine through an infusion pump.
Amyotrophic Lateral Sclerosis Prevention: Neurodegenerative Diseases Offer Insight
Researchers sought to develop a “roadmap” to early intervention and disease prevention for ALS by observing advances in neurodegenerative diseases with a presymptomatic period.
Novel Pramipexole-Rasagiline Combo Promising for Early Parkinson Disease
The fixed-dose combination therapy was found to be superior to each component.
Treating Motor Symptoms in Early Parkinson Disease: AAN Releases New Guidelines
In an update to treatment strategies for motor symptoms in early Parkinson disease, the American Academy of Neurology has reviewed the research on the benefits and risks of available medications.
AAN Updates Recommendations for Early Parkinson Disease Treatment
Counseling should be provided to individuals with early Parkinson disease on the benefits and risks of initiating treatment.
Focused Ultrasound Device Approved for Advanced Parkinson Disease
Patients are awake and responsive during the whole treatment duration.
Continuous SC Infusion Therapy Bests Oral Levodopa/Carbidopa in Parkinson Trial
The randomized, double-blind, double-dummy, active-controlled study compared ABBV-951 via continuous SC infusion to oral levodopa/carbidopa.
Inosine Fails to Slow Early Parkinson Disease Progression in Phase 3 Trial
Researchers assessed the impact of oral inosine, a metabolic precursor of urate, on disease progression in patients with early Parkinson disease.
Boxing Therapy May Reduce Risk for Falls in Patients With Parkinson Disease
Researchers observed the effect of boxing therapy on overall coordination, gait, and balance in patients with Parkinson disease before, during, and after the COVID-19 lockdown.
- Loading...
Loading...
Next post in News
Loading... 
Loading...